NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for Acusphere Inc


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Acusphere Announces Change In Imagify Regulatory Strategy and Deferral of Near-Term Contractual Cash Payments
2009 MAR 2 ... Acusphere Inc. (OTCBB: ACUS) announced that it has submitted an amendment to its New Drug Application ...
Subject: Acusphere Inc.
Price: $3.00
*
Acusphere Announces Further Cost Reductions and Voluntary Filing of Form 15 to Suspend SEC Reporting Obligations
2009 MAR 16 ... Acusphere Inc. (OTCBB: ACUS) announced its plan to substantially reduce costs while it continues its ...
Subject: Acusphere Inc.
Price: $3.00
*
Acusphere Receives Complete Response from FDA
2009 MAR 23 ... Regulatory Actions, Therapy, Treatment, U.S. Food and Drug Administration, Acusphere Inc. This article was prepared by Biotech Business Week editors from staff ...
Subject: Acusphere, Inc.
Price: $3.00
*
Acusphere, Inc. Announces Amended Terms of Cephalon Agreements
2009 JUL 6 ... Drug Delivery, Drugs, Medical Device, Oncology, Pharmaceuticals, Therapy, Treatment, Acusphere Inc. This article was prepared by Biotech Business Week editors from staff and ...
Subject: Acusphere, Inc.
Price: $3.00
*
Acusphere, Inc. Announces Prepayment of Equipment Loans
2009 JUN 8 ... Regulatory Actions, Therapy, Treatment, U.S. Food and Drug Administration, Acusphere Inc. This article was prepared by Biotech Business Week editors from staff ...
Subject: Acusphere, Inc.
Price: $3.00
*
Acusphere, Inc. Announces Receipt of NASDAQ Panel Decision to Delist Common Stock
2009 JAN 20 ... Acusphere, Inc. (NASDAQ:ACUS) announced that it has received notification that the NASDAQ Listing ...
Subject: Acusphere, Inc.
Price: $3.00
*
Acusphere, Inc. Announces Resignation of Richard Walovitch
2009 JAN 19 ... Acusphere, Inc. (NASDAQ: ACUS) announced that Dr. Richard Walovitch, Senior Vice President of ...
Subject: Acusphere, Inc.
Price: $3.00
*
Acusphere, Inc. Reports Q4 2008 Recent Business Highlights, Business Priorities and Financial Results
2009 APR 13 ... Medical Device, Perfusion, Therapy, Treatment, U.S. Food and Drug Administration, Acusphere Inc. This article was prepared by Biotech Business Week editors from staff ...
Subject: Acusphere, Inc.
Price: $3.00
*
Aseptic Spray-Drying - Hovione's Latest Offering
2009 NOV 3 ... an aseptic spray-drying production line, vial filling and back up utilities from Acusphere, a company located in Boston. The equipment includes sterile filtration, ...
Subject: Hovione
Price: $3.00
*
ViroPharma Announces Appointment of Frank Baldino, Jr., Ph.D. to Board of Directors
2009 JUN 22 ... BIO. Dr. Baldino is also a member of the Board of Directors for NicOx, S.A., and Acusphere, Inc. Keywords: Biopharmaceuticals, Biotechnology Business, Biotechnology ...
Subject: Biopharmaceuticals
Price: $3.00
*
Acusphere Announces Closing of Transaction with Cephalon
2008 NOV 17 ... Business, Biotechnology Company, Cephalon, Clinical Trials, Pre-Trials Research, Acusphere Inc. This article was prepared by Biotech Business Week editors from staff ...
Subject: Acusphere, Inc.
Price: $3.00
*
Acusphere Announces Data Demonstrating Imagify Perfusion Stress Echo Predicts Presence of Coronary Artery Disease
2008 NOV 24 ... Echocardiography, Heart Attack, Heart Disease, Imaging Agent, Medical Device, Perfusion, Acusphere Inc. This article was prepared by Pain & Central Nervous System Week editors ...
Subject: Acusphere, Inc.
Price: $3.00
*
Acusphere Announces Signing of a Definitive Agreement with Cephalon
2008 NOV 10 ... Rheumatoid Arthritis, Therapy, Toradol, Treatment, U.S. Food and Drug Administration, Acusphere Inc. This article was prepared by Pain & Central Nervous System Week editors ...
Subject: Acusphere, Inc.
Price: $3.00
*
Acusphere Announces Staff Reductions
2008 AUG 11 ... Acusphere Inc. (NASDAQ: ACUS) announced that it has reduced its employee base by 24 people, or about ...
Subject: Acusphere, Inc.
Price: $3.00
*
Acusphere, Inc. Appoints Michael Slater SVP Regulatory Affairs and Operations Replacing Dennis Bucceri
2008 OCT 6 ... Acusphere, Inc. (NASDAQ: ACUS) announced that Michael R. Slater will assume the position of Senior ...
Subject: Acusphere, Inc.
Price: $3.00
*
Acusphere, Inc. Reports Q2 2008 Financial Results and Business Highlights
2008 AUG 25 ... Acusphere, Inc. (NASDAQ: ACUS) reported financial results for the second quarter ended June 30, ...
Subject: Acusphere, Inc.
Price: $3.00
*
Acusphere, Inc. Reports Q3 2008 Financial Results and Business Highlights
2008 NOV 24 ... Research, Regulatory Actions, Therapy, Treatment, U.S. Food and Drug Administration, Acusphere Inc. This article was prepared by Biotech Business Week editors from staff ...
Subject: Acusphere, Inc.
Price: $3.00
*
Recent studies from Acusphere, Inc. add new data to life sciences
2008 JUL 28 ... over milling the raw drug alone (process B)," wrote R.A. Jain and colleagues, Acusphere, Inc. The researchers concluded: "Process C yielded bulk powder that ...
Subject: Life Sciences
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login